封面
市场调查报告书
商品编码
1939506

成犬营养补充品市场:依健康功能、供应类型、成分类型和销售管道,全球预测(2026-2032年)

Adult Dog Supplement Market by Health Function, Delivery Form, Ingredient Type, Sales Channel - Global Forecast 2026-2032

出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年,成年犬营养补充品市场价值将达到 9.6311 亿美元,到 2026 年将成长至 10.2025 亿美元,到 2032 年将达到 15.2227 亿美元,复合年增长率为 6.75%。

关键市场统计数据
基准年 2025 9.6311亿美元
预计年份:2026年 1,020,250,000 美元
预测年份 2032 1,522,270,000 美元
复合年增长率 (%) 6.75%

对影响成犬营养补充品市场的各种因素进行权威说明,重点在于消费者期望、监管现况、创新先决条件。

成犬营养补充品市场正处于一个转折点,科技进步、宠物饲主日益增长的期望以及不断变化的零售环境共同作用,重新定义了产品开发和商业化策略。随着宠物越来越被视为家庭成员,市场推动要素也从基本的健康维护扩展到特定的功能性益处、预防保健和健康优化。同时,成分创新和临床检验也提高了消费者对产品功效和透明度的期望,迫使品牌围绕检验的证据和清晰的使用指南来建立产品故事。

近期科学进步、数位商务发展和供应链韧性如何重新定义成年犬营养补充品利害关係人的策略重点

近年来,成犬营养补充品市场经历了许多变革,为相关人员带来了新的机会和营运挑战。首先,成分科学的日益成熟和物种特异性研究的积累,使得功能性配方更加精准,益生菌菌株选择、ω脂肪酸来源以及关节健康活性成分等方面的进步,都为产品功效的宣称提供了有力支撑。因此,基于实证的定位已从竞争优势转变为精明消费者的基本需求。

评估2025年生效的新关税措施对成年犬营养补充品国际采购和分销的韧性和产品定位的营运和策略影响

2025年推出的关税政策和贸易措施为依赖国际采购活性成分和成品的企业带来了巨大挑战。部分进口零件关税的提高促使企业紧急重新评估筹资策略。采购部门正在探索替代供应商、寻找在地采购机会,并调整原料组合,以降低成本并维持产品市场地位。因此,采购週期正在缩短,采购实质审查也变得更加细緻,不仅关注价格,还关注物流柔软性和地缘政治风险。

透过对健康功能、给药形式、成分类型和销售管道等关键细分市场的洞察,制定切实可行的产品和通路策略。

了解细分市场的细微差别对于优化成犬营养补充品产品组合的创新重点和商业性策略至关重要。从健康功能角度审视产品时,会涌现出不同的开发路径,例如强调益生元和益生菌的消化健康解决方案、基于抗氧化剂和维生素C的免疫支持产品、以软骨素和氨基葡萄糖为中心的关节健康配方,以及添加生物素和ω脂肪酸的皮肤和毛髮护理产品。每个功能丛集都面临着独特的配方挑战、剂量预期和临床验证需求,这些都会影响监管讯息和兽医的接受度。

区域趋势和当地需求正在塑造美洲、欧洲、中东和非洲以及亚太地区的合规和分销策略。

在成犬营养补充品领域,区域趋势对产品偏好、法规结构和商业性执行有显着影响。在美洲,消费者对便利性和功能性的追求推动了对偏好性和科学依据的产品的强劲需求,而零售商则强调全通路供货和与宠物季节性护理需求相符的促销週期。主要市场的监管路径强调了精心选择的标籤和严格的安全文件的重要性,这会影响产品开发週期和合作伙伴的选择。

领先企业如何结合科学检验、供应链透明度和全通路覆盖,在成犬营养补充品领域树立新的领导标准

成犬营养补充品领域的主要企业透过整合配方科学、严格的供应链管理和通路定向分销,打造差异化优势。产业领导者投资于临床伙伴关係,以证实产品功效并赢得兽医的信任,同时建立完善的采购体系,优先考虑可追溯性和品管。这些公司也利用数位化商品行销、订阅模式和专家推荐,建构覆盖不同客户群的多通路分销策略。

加强科学信誉、实现采购多元化以及优化通路特定产品和数位化策略的实用建议

为了掌握不断演变的成犬营养补充品市场的机会并降低风险,产业领导者应在研发、商业营运和供应链管理方面采取协调一致的策略行动。首先,应优先投资于针对特定犬种的临床检验和第三方分析测试,以佐证产品功效并建立消费者和兽医专业人士的信任。这将有助于品牌维持高端定价,并获得专家认可,从而鼓励消费者试用和重复购买。

采用透明的调查方法,结合一手访谈、二手研究和跨细分市场分析,得出具有实际操作价值的洞见。

本研究综合分析基于结构化的多面向方法,结合了主要相关人员访谈、二手文献综述和跨职能检验,以确保获得平衡且可操作的见解。关键输入包括与来自製剂科学、采购、零售营运和兽医实践等领域的行业从业人员的讨论,这些讨论为需求驱动因素、推广障碍和通路动态的定性解读提供了依据。此外,还对同行评审的研究文章、监管指导文件和已发布的行业资讯披露进行了系统性回顾,以现有证据支持产品层面的声明。

我们的策略结论强调,需要将科学严谨性、采购韧性和分销管道执行力相结合,以确保在成年犬营养补充剂领域取得长期成功。

总之,目前,成犬营养补充品市场的成功主要归功于那些将严谨的科学研究、可靠的原料采购和通路行销结合的企业。诸如利用益生元和益生菌支持消化系统,或依靠软骨素和葡萄糖胺维护关节健康等功能性产品,都需要客製化的配方专业知识和清晰的临床沟通。同时,剂型和成分类型必须与消费者的偏好和稳定性要求相匹配,以确保产品的有效性和便利性。

目录

第一章:序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵,2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章:美国关税的累积影响,2025年

第七章:人工智慧的累积影响,2025年

第八章:以健康功能分類的成年犬营养补充品市场

  • 消化系统健康
    • 益生元
    • 益生菌
  • 免疫支持
    • 抗氧化剂
    • 维生素C
  • 关节健康
    • 软骨素
    • 葡萄糖胺
  • 皮肤和毛髮健康
    • 生物素
    • 欧米伽脂肪酸

9. 按剂型分類的成犬营养补充品市场

  • 液体
  • 粉末
  • 小吃
  • 片剂和软咀嚼片

第十章 依成分类型分類的成犬营养补充品市场

  • 草药萃取物
  • 欧米伽脂肪酸
  • 益生菌
  • 维生素和矿物质

第十一章 成年犬营养补充品市场销售管道

  • 线下零售店
  • 线上/电子商务

第十二章:各地区成年犬营养补充品市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 成犬营养补充品市场(依类别划分)

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国成年犬营养补充品市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

15. 美国成年犬营养补充品市场

第十六章 中国成犬营养补充品市场

第十七章 竞争格局

  • 市场集中度分析,2025年
    • 浓度比(CR)
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析,2025 年
  • 2025年产品系列分析
  • 基准分析,2025 年
  • Bayer Aktiengesellschaft
  • Elanco Animal Health Incorporated
  • Kemin Industries, Inc.
  • Mars, Incorporated
  • Merck & Co., Inc.
  • Nestle Purina PetCare Company
  • Nutramax Laboratories, Inc.
  • Schell & Kampeter, Inc.
  • Spectrum Brands Holdings, Inc.
  • Vetoquinol SA
  • Virbac SA
  • Wellness Pet, LLC
  • Zoetis Inc.
Product Code: MRR-9A6A6F2977E2

The Adult Dog Supplement Market was valued at USD 963.11 million in 2025 and is projected to grow to USD 1,020.25 million in 2026, with a CAGR of 6.75%, reaching USD 1,522.27 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 963.11 million
Estimated Year [2026] USD 1,020.25 million
Forecast Year [2032] USD 1,522.27 million
CAGR (%) 6.75%

An authoritative introduction to the forces shaping adult dog supplements that clarifies consumer expectations regulatory realities and innovation prerequisites

The adult dog supplement category is experiencing a convergence of scientific advances, heightened pet owner expectations, and evolving retail dynamics that collectively redefine product development and commercialization strategies. As companion animals are increasingly viewed as family members, demand drivers now extend beyond basic health maintenance into targeted functional benefits, preventive care, and wellness optimization. Concurrently, ingredient innovation and clinical validation have elevated expectations for product claims and transparency, prompting brands to align formulation narratives with verifiable evidence and clear usage guidance.

Moreover, regulatory attention and labeling scrutiny have intensified, making compliance and supply chain traceability essential components of go-to-market readiness. In turn, manufacturers and brand owners must invest in robust quality assurance frameworks and strategic supplier relationships to maintain credibility. Across channels, consumer shopping behaviors emphasize convenience and education, favoring formats and messaging that simplify administration while clearly communicating benefit pathways. Taken together, these dynamics set the stage for companies to prioritize science-led differentiation, omnichannel visibility, and operational resilience to succeed in the adult dog supplement arena.

How recent scientific advances digital commerce evolution and supply chain resilience are collectively redefining strategic priorities for adult dog supplement stakeholders

In recent years the landscape for adult dog supplements has been reshaped by several transformative shifts that interact to create new opportunities and operational complexities for stakeholders. First, the maturation of ingredient science and a growing body of species-specific research have enabled more precise functional formulations, with advances in probiotic strain selection, omega fatty acid sourcing, and joint health actives informing product efficacy claims. As a result, evidence-based positioning has moved from a competitive advantage to a baseline expectation among informed buyers.

At the same time, distribution models have evolved as digital commerce scales and direct-to-consumer channels introduce new touchpoints for education and trial. Retailers and brands now emphasize subscription options, personalized recommendations, and content-driven commerce to increase lifetime value. Meanwhile, heightened consumer demand for transparency is prompting investments in traceability technologies and clearer labeling, which dovetails with regulatory scrutiny to ensure safety and authenticity. Finally, supply chain resilience and ethical sourcing have transitioned from aspirational goals to operational imperatives, influencing supplier selection, ingredient inventories, and contingency planning. Collectively these shifts require companies to balance scientific rigor, digital engagement, and robust supply chain governance in order to remain competitive.

Assessing the operational and strategic consequences of new 2025 tariff measures on international sourcing distribution resilience and product positioning in adult dog supplements

Tariff policies and trade measures introduced in 2025 have introduced notable headwinds for companies reliant on international sourcing of active ingredients and finished goods. Increased duties on certain imported components have necessitated a reassessment of procurement strategies, with procurement teams evaluating alternative suppliers, local sourcing opportunities, and ingredient reformulations to mitigate cost impacts and preserve product positioning. Consequently, procurement cycles have shortened and sourcing due diligence has become more granular, focusing not only on price but on logistical agility and geopolitical risk exposure.

In addition, these tariff shifts have accelerated conversations around nearshoring and vertical integration as long-term risk management strategies. Manufacturers that can localize critical stages of the supply chain or secure multi-sourced ingredient pipelines gain flexibility to respond to future trade fluctuations. At the same time, brands with established premium positioning face the challenge of maintaining price-value perceptions while absorbing or passing through increased costs. For many firms, the practical outcomes of these policy changes include renegotiated supplier agreements, redesigned packaging to optimize freight, and intensified monitoring of cross-border compliance requirements. Transitioning through these impacts demands a rigorous approach to cost-to-serve analysis and scenario planning to preserve product integrity and customer trust.

Critical segmentation insights that connect health functions delivery forms ingredient types and sales channels to actionable product and channel strategies

A nuanced understanding of segmentation is essential to prioritize innovation and tailor commercial approaches across the adult dog supplement portfolio. When products are considered through the lens of health function, distinct development pathways emerge for digestive health solutions that emphasize prebiotics and probiotics, immune support offerings that rely on antioxidants and vitamin C, joint health formulations centered on chondroitin and glucosamine, and skin and coat treatments that deploy biotin and omega fatty acids. Each functional cluster carries unique formulation challenges, dosing expectations, and clinical support needs, which in turn influence regulatory messaging and veterinarian acceptance.

Delivery form is another critical axis that shapes consumer adoption and manufacturing processes. Liquid formats, powders, snacks, and tablets and soft chews each address different administration preferences and age or size considerations. Liquid and powder options often appeal to owners seeking customizable dosing or ease of mixing, whereas snacks and soft chews prioritize palatability and convenience for everyday use. Ingredient type further refines positioning, with herbal extracts, omega fatty acids, probiotics, and vitamins and minerals offering diverse sourcing, stability, and efficacy profiles that require tailored supply chain controls and analytical testing regimes.

Sales channels complete the segmentation picture by dictating purchasing contexts and promotional strategies. Mass retailers, online retail, pet specialty stores, and veterinary clinics present divergent expectations for claims substantiation, merchandising, and education. Within mass retail, discount stores and supermarkets and hypermarkets demand scale-ready packaging and price competitiveness, while brand websites, e-commerce platforms, and marketplaces in the online retail environment require rich content, fulfillment excellence, and customer service integration. Pet specialty stores and veterinary clinics often prioritize clinician-endorsed evidence and professional samples, making targeted clinical data and point-of-sale educational materials particularly valuable. Integrating these segmentation lenses enables organizations to align formulation choices, packaging design, and go-to-market tactics with the behaviors and needs of each customer cohort.

Regional dynamics and localized imperatives shaping formulation regulatory compliance and distribution strategies across the Americas Europe Middle East Africa and Asia Pacific

Regional dynamics exert a powerful influence on product preferences regulatory frameworks and commercial execution in the adult dog supplement space. In the Americas, consumer affinity for convenience and functional benefits drives strong interest in palatable formats and scientifically substantiated claims, with retailers emphasizing omnichannel availability and promotional cycles tied to seasonal pet care needs. Regulatory pathways in key markets underscore the need for carefully curated labeling language and rigorous safety documentation, which informs product development timelines and partner selection.

Europe, the Middle East & Africa present a diverse regulatory and cultural tapestry that requires localized strategies for ingredient approvals, labeling translations, and sustainability narratives. In parts of this region, consumers demonstrate heightened sensitivity to natural and ethically sourced ingredients, prompting brands to foreground provenance and certification. Retail structures vary widely, so distribution strategies must be tailored to national buying habits and professional veterinary influence.

Across the Asia-Pacific region, rapid growth in pet ownership and rising disposable income have accelerated demand for premium supplements and novel delivery formats. Consumers in several markets are particularly receptive to scientifically communicated benefits and brands that provide clear consumption guidance. For companies operating across these regions, success depends on harmonizing global evidence packages with local regulatory compliance, translating education into native languages, and aligning packaging and logistics to regional retail formats and fulfillment expectations.

How top-tier firms are combining scientific validation supply chain transparency and omnichannel execution to set new standards in adult dog supplement leadership

Leading companies in the adult dog supplement space are distinguishing themselves through integrated approaches that combine formulation science, supply chain rigor, and channel-specific enablement. Industry leaders invest in clinical partnerships to substantiate claims and build veterinarian trust, while simultaneously establishing resilient sourcing frameworks that prioritize traceability and quality control. These firms also cultivate multi-channel go-to-market playbooks that leverage digital merchandising, subscription models, and professional endorsements to reach a diverse customer base.

Furthermore, competitive differentiation often arises from platform-level investments in consumer education and brand experience. Companies that produce clear dosing guidance, transparent ingredient traceability, and compelling evidence summaries tend to secure stronger retailer relationships and higher conversion rates online. On the operations side, leaders are adopting modular manufacturing and secondary packaging strategies to accommodate channel-specific packaging requirements and to optimize logistics costs. Strategic partnerships with ingredient innovators and contract manufacturers support faster iteration and scale-up, enabling these companies to respond quickly to emerging functional trends and regulatory developments.

Actionable recommendations for leaders to fortify scientific credibility diversify sourcing and optimize channel-specific product and digital strategies

To capture opportunity and mitigate risk in the evolving adult dog supplement environment, industry leaders should undertake coordinated strategic actions across R&D commercial operations and supply chain management. First, prioritize investment in species-specific clinical validation and third-party analytical testing to underpin claims and build credibility with both consumers and veterinary professionals. By doing so, brands will be better positioned to defend premium price points and secure professional endorsements that drive trial and repeat purchase.

Second, diversify sourcing strategies to reduce exposure to single-source suppliers and tariff-related disruptions. This includes qualifying alternative ingredient suppliers, exploring nearshore manufacturing partnerships, and building inventory buffers for critical actives. Third, tailor product portfolios and packaging to channel preferences by aligning delivery forms and merchandising assets with the expectations of mass retailers, online platforms, pet specialty stores, and veterinary clinics. Finally, enhance digital customer journeys through educational content, subscription models, and post-purchase engagement that reinforces compliance and long-term loyalty. Implementing these recommendations will help organizations deliver consistent product performance, preserve margins, and accelerate adoption across varied consumer segments.

Transparent methodology explaining how primary interviews secondary research and cross-segmentation analysis were combined to produce operationally relevant insights

This research synthesis draws on a structured, multi-method approach combining primary stakeholder interviews, secondary literature review, and cross-functional validation to ensure balanced and actionable insights. Primary inputs included discussions with industry practitioners across formulation science, procurement, retail operations, and veterinary practice, which informed qualitative interpretations of demand drivers, adoption barriers, and channel dynamics. These conversations were complemented by systematic review of peer-reviewed studies, regulatory guidance documents, and public industry disclosures to ground product-level claims in available evidence.

Analytical techniques included cross-segmentation mapping to identify where functional benefits align with preferred delivery forms and channel requirements, as well as sensitivity analysis to evaluate the operational implications of policy shifts such as tariff changes. Findings were iteratively validated through expert panel reviews to refine conclusions and prioritize recommendations. Throughout the process, emphasis was placed on traceable sourcing of evidence, transparent assumptions, and the practical relevance of insights for commercial decision-makers seeking to translate research into product and channel strategies.

Strategic conclusion emphasizing the necessity of aligning scientific rigor sourcing resilience and channel execution to secure long term success in adult dog supplements

In conclusion, the adult dog supplement category now rewards organizations that combine rigorous science, resilient sourcing, and channel-aware commercialization. Functional specificity, whether in digestive support leveraging prebiotics and probiotics or in joint health relying on chondroitin and glucosamine, demands tailored formulation expertise and clear clinical communication. At the same time, delivery forms and ingredient types must be synchronized with consumer preferences and stability requirements to ensure both efficacy and convenience.

Looking ahead, companies that invest in proof points, diversify supply chains, and customize their go-to-market tactics for regional and channel nuances will be best positioned to capture sustainable value. Transitioning from reactive to strategic planning-by embedding regulatory compliance, traceability, and consumer education into product lifecycles-will enable brands to deliver differentiated outcomes for dogs and owners alike. Ultimately, pragmatic alignment of science, sourcing, and sales execution is the most reliable path to building trust and long-term growth in this dynamic category.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Adult Dog Supplement Market, by Health Function

  • 8.1. Digestive Health
    • 8.1.1. Prebiotics
    • 8.1.2. Probiotics
  • 8.2. Immune Support
    • 8.2.1. Antioxidants
    • 8.2.2. Vitamin C
  • 8.3. Joint Health
    • 8.3.1. Chondroitin
    • 8.3.2. Glucosamine
  • 8.4. Skin And Coat Health
    • 8.4.1. Biotin
    • 8.4.2. Omega Fatty Acids

9. Adult Dog Supplement Market, by Delivery Form

  • 9.1. Liquid
  • 9.2. Powders
  • 9.3. Snacks
  • 9.4. Tablets And Soft Chews

10. Adult Dog Supplement Market, by Ingredient Type

  • 10.1. Herbal Extracts
  • 10.2. Omega Fatty Acids
  • 10.3. Probiotics
  • 10.4. Vitamins And Minerals

11. Adult Dog Supplement Market, by Sales Channel

  • 11.1. Offline Retail Stores
  • 11.2. Online / E-commerce

12. Adult Dog Supplement Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Adult Dog Supplement Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Adult Dog Supplement Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Adult Dog Supplement Market

16. China Adult Dog Supplement Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Bayer Aktiengesellschaft
  • 17.6. Elanco Animal Health Incorporated
  • 17.7. Kemin Industries, Inc.
  • 17.8. Mars, Incorporated
  • 17.9. Merck & Co., Inc.
  • 17.10. Nestle Purina PetCare Company
  • 17.11. Nutramax Laboratories, Inc.
  • 17.12. Schell & Kampeter, Inc.
  • 17.13. Spectrum Brands Holdings, Inc.
  • 17.14. Vetoquinol SA
  • 17.15. Virbac SA
  • 17.16. Wellness Pet, LLC
  • 17.17. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ADULT DOG SUPPLEMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ADULT DOG SUPPLEMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY HEALTH FUNCTION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY DELIVERY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ADULT DOG SUPPLEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ADULT DOG SUPPLEMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY HEALTH FUNCTION, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY DIGESTIVE HEALTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY DIGESTIVE HEALTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY DIGESTIVE HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY PREBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY PREBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY PROBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY PROBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY IMMUNE SUPPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY IMMUNE SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY IMMUNE SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY IMMUNE SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY ANTIOXIDANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY ANTIOXIDANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY ANTIOXIDANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY VITAMIN C, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY VITAMIN C, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY VITAMIN C, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY JOINT HEALTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY JOINT HEALTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY JOINT HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY JOINT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY CHONDROITIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY CHONDROITIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY CHONDROITIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY GLUCOSAMINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY GLUCOSAMINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY GLUCOSAMINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY SKIN AND COAT HEALTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY SKIN AND COAT HEALTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY SKIN AND COAT HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY BIOTIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY BIOTIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY BIOTIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY OMEGA FATTY ACIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY OMEGA FATTY ACIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY OMEGA FATTY ACIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY DELIVERY FORM, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY POWDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY POWDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY POWDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY SNACKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY SNACKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY SNACKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY TABLETS AND SOFT CHEWS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY TABLETS AND SOFT CHEWS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY TABLETS AND SOFT CHEWS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY HERBAL EXTRACTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY HERBAL EXTRACTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY HERBAL EXTRACTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY OMEGA FATTY ACIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY OMEGA FATTY ACIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY OMEGA FATTY ACIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY PROBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY PROBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY VITAMINS AND MINERALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY VITAMINS AND MINERALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY VITAMINS AND MINERALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY OFFLINE RETAIL STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY OFFLINE RETAIL STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY OFFLINE RETAIL STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY ONLINE / E-COMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY ONLINE / E-COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY ONLINE / E-COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS ADULT DOG SUPPLEMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS ADULT DOG SUPPLEMENT MARKET SIZE, BY HEALTH FUNCTION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS ADULT DOG SUPPLEMENT MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS ADULT DOG SUPPLEMENT MARKET SIZE, BY IMMUNE SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS ADULT DOG SUPPLEMENT MARKET SIZE, BY JOINT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS ADULT DOG SUPPLEMENT MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS ADULT DOG SUPPLEMENT MARKET SIZE, BY DELIVERY FORM, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS ADULT DOG SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS ADULT DOG SUPPLEMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA ADULT DOG SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA ADULT DOG SUPPLEMENT MARKET SIZE, BY HEALTH FUNCTION, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA ADULT DOG SUPPLEMENT MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA ADULT DOG SUPPLEMENT MARKET SIZE, BY IMMUNE SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA ADULT DOG SUPPLEMENT MARKET SIZE, BY JOINT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA ADULT DOG SUPPLEMENT MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA ADULT DOG SUPPLEMENT MARKET SIZE, BY DELIVERY FORM, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA ADULT DOG SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA ADULT DOG SUPPLEMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA ADULT DOG SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA ADULT DOG SUPPLEMENT MARKET SIZE, BY HEALTH FUNCTION, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA ADULT DOG SUPPLEMENT MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA ADULT DOG SUPPLEMENT MARKET SIZE, BY IMMUNE SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA ADULT DOG SUPPLEMENT MARKET SIZE, BY JOINT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA ADULT DOG SUPPLEMENT MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA ADULT DOG SUPPLEMENT MARKET SIZE, BY DELIVERY FORM, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA ADULT DOG SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA ADULT DOG SUPPLEMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA ADULT DOG SUPPLEMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ADULT DOG SUPPLEMENT MARKET SIZE, BY HEALTH FUNCTION, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA ADULT DOG SUPPLEMENT MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA ADULT DOG SUPPLEMENT MARKET SIZE, BY IMMUNE SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA ADULT DOG SUPPLEMENT MARKET SIZE, BY JOINT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA ADULT DOG SUPPLEMENT MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA ADULT DOG SUPPLEMENT MARKET SIZE, BY DELIVERY FORM, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA ADULT DOG SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA ADULT DOG SUPPLEMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE ADULT DOG SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE ADULT DOG SUPPLEMENT MARKET SIZE, BY HEALTH FUNCTION, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE ADULT DOG SUPPLEMENT MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE ADULT DOG SUPPLEMENT MARKET SIZE, BY IMMUNE SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE ADULT DOG SUPPLEMENT MARKET SIZE, BY JOINT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE ADULT DOG SUPPLEMENT MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE ADULT DOG SUPPLEMENT MARKET SIZE, BY DELIVERY FORM, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE ADULT DOG SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE ADULT DOG SUPPLEMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST ADULT DOG SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST ADULT DOG SUPPLEMENT MARKET SIZE, BY HEALTH FUNCTION, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST ADULT DOG SUPPLEMENT MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST ADULT DOG SUPPLEMENT MARKET SIZE, BY IMMUNE SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST ADULT DOG SUPPLEMENT MARKET SIZE, BY JOINT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST ADULT DOG SUPPLEMENT MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST ADULT DOG SUPPLEMENT MARKET SIZE, BY DELIVERY FORM, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST ADULT DOG SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST ADULT DOG SUPPLEMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA ADULT DOG SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA ADULT DOG SUPPLEMENT MARKET SIZE, BY HEALTH FUNCTION, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA ADULT DOG SUPPLEMENT MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA ADULT DOG SUPPLEMENT MARKET SIZE, BY IMMUNE SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA ADULT DOG SUPPLEMENT MARKET SIZE, BY JOINT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA ADULT DOG SUPPLEMENT MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA ADULT DOG SUPPLEMENT MARKET SIZE, BY DELIVERY FORM, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA ADULT DOG SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA ADULT DOG SUPPLEMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC ADULT DOG SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC ADULT DOG SUPPLEMENT MARKET SIZE, BY HEALTH FUNCTION, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC ADULT DOG SUPPLEMENT MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC ADULT DOG SUPPLEMENT MARKET SIZE, BY IMMUNE SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC ADULT DOG SUPPLEMENT MARKET SIZE, BY JOINT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC ADULT DOG SUPPLEMENT MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC ADULT DOG SUPPLEMENT MARKET SIZE, BY DELIVERY FORM, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC ADULT DOG SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC ADULT DOG SUPPLEMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN ADULT DOG SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN ADULT DOG SUPPLEMENT MARKET SIZE, BY HEALTH FUNCTION, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN ADULT DOG SUPPLEMENT MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN ADULT DOG SUPPLEMENT MARKET SIZE, BY IMMUNE SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN ADULT DOG SUPPLEMENT MARKET SIZE, BY JOINT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN ADULT DOG SUPPLEMENT MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN ADULT DOG SUPPLEMENT MARKET SIZE, BY DELIVERY FORM, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN ADULT DOG SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN ADULT DOG SUPPLEMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. GCC ADULT DOG SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. GCC ADULT DOG SUPPLEMENT MARKET SIZE, BY HEALTH FUNCTION, 2018-2032 (USD MILLION)
  • TABLE 161. GCC ADULT DOG SUPPLEMENT MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
  • TABLE 162. GCC ADULT DOG SUPPLEMENT MARKET SIZE, BY IMMUNE SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 163. GCC ADULT DOG SUPPLEMENT MARKET SIZE, BY JOINT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 164. GCC ADULT DOG SUPPLEMENT MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 165. GCC ADULT DOG SUPPLEMENT MARKET SIZE, BY DELIVERY FORM, 2018-2032 (USD MILLION)
  • TABLE 166. GCC ADULT DOG SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. GCC ADULT DOG SUPPLEMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION ADULT DOG SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION ADULT DOG SUPPLEMENT MARKET SIZE, BY HEALTH FUNCTION, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION ADULT DOG SUPPLEMENT MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION ADULT DOG SUPPLEMENT MARKET SIZE, BY IMMUNE SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION ADULT DOG SUPPLEMENT MARKET SIZE, BY JOINT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION ADULT DOG SUPPLEMENT MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION ADULT DOG SUPPLEMENT MARKET SIZE, BY DELIVERY FORM, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION ADULT DOG SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION ADULT DOG SUPPLEMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS ADULT DOG SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS ADULT DOG SUPPLEMENT MARKET SIZE, BY HEALTH FUNCTION, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS ADULT DOG SUPPLEMENT MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS ADULT DOG SUPPLEMENT MARKET SIZE, BY IMMUNE SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS ADULT DOG SUPPLEMENT MARKET SIZE, BY JOINT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS ADULT DOG SUPPLEMENT MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS ADULT DOG SUPPLEMENT MARKET SIZE, BY DELIVERY FORM, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS ADULT DOG SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS ADULT DOG SUPPLEMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 186. G7 ADULT DOG SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. G7 ADULT DOG SUPPLEMENT MARKET SIZE, BY HEALTH FUNCTION, 2018-2032 (USD MILLION)
  • TABLE 188. G7 ADULT DOG SUPPLEMENT MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
  • TABLE 189. G7 ADULT DOG SUPPLEMENT MARKET SIZE, BY IMMUNE SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 190. G7 ADULT DOG SUPPLEMENT MARKET SIZE, BY JOINT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 191. G7 ADULT DOG SUPPLEMENT MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 192. G7 ADULT DOG SUPPLEMENT MARKET SIZE, BY DELIVERY FORM, 2018-2032 (USD MILLION)
  • TABLE 193. G7 ADULT DOG SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. G7 ADULT DOG SUPPLEMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. NATO ADULT DOG SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. NATO ADULT DOG SUPPLEMENT MARKET SIZE, BY HEALTH FUNCTION, 2018-2032 (USD MILLION)
  • TABLE 197. NATO ADULT DOG SUPPLEMENT MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
  • TABLE 198. NATO ADULT DOG SUPPLEMENT MARKET SIZE, BY IMMUNE SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 199. NATO ADULT DOG SUPPLEMENT MARKET SIZE, BY JOINT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 200. NATO ADULT DOG SUPPLEMENT MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 201. NATO ADULT DOG SUPPLEMENT MARKET SIZE, BY DELIVERY FORM, 2018-2032 (USD MILLION)
  • TABLE 202. NATO ADULT DOG SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. NATO ADULT DOG SUPPLEMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL ADULT DOG SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES ADULT DOG SUPPLEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES ADULT DOG SUPPLEMENT MARKET SIZE, BY HEALTH FUNCTION, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED STATES ADULT DOG SUPPLEMENT MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES ADULT DOG SUPPLEMENT MARKET SIZE, BY IMMUNE SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES ADULT DOG SUPPLEMENT MARKET SIZE, BY JOINT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES ADULT DOG SUPPLEMENT MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES ADULT DOG SUPPLEMENT MARKET SIZE, BY DELIVERY FORM, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES ADULT DOG SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES ADULT DOG SUPPLEMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. CHINA ADULT DOG SUPPLEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 215. CHINA ADULT DOG SUPPLEMENT MARKET SIZE, BY HEALTH FUNCTION, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA ADULT DOG SUPPLEMENT MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA ADULT DOG SUPPLEMENT MARKET SIZE, BY IMMUNE SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA ADULT DOG SUPPLEMENT MARKET SIZE, BY JOINT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA ADULT DOG SUPPLEMENT MARKET SIZE, BY SKIN AND COAT HEALTH, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA ADULT DOG SUPPLEMENT MARKET SIZE, BY DELIVERY FORM, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA ADULT DOG SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA ADULT DOG SUPPLEMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)